Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) Q3 2025 Earnings Call Transcript November 12, 2025 Acurx Pharmaceuticals, Inc.

Q3 2025 Earnings Call Transcript November 12, 2025 Abeona Therapeutics Inc. beats earnings expectations. Reported EPS is ...

Increased 5% with management citing ongoing focus on profitable accounts. Technology Platform Development -- Infusion of ...

Operator: Good morning. Welcome to Kamada Ltd. third quarter 2025 earnings conference call. At this time, all participants ...

Earlier this morning, the company announced its operating results for the three months ended September 30, 2025. Kras reviews ...

Corey and Christine will provide an update on the commercial launch of Orlynda in the U.S. Corey will also give an update on ...

The Shrine Bowl all-star game pits top senior players from South Carolina against those from North Carolina. Dorman High School was the only school with two players named to the South Carolina roster.

Net Loss -- $7.5 million, translating to negative $0.38 per share, with an operating loss of $7 million, improved from a ...

Florida Expansion -- Delegated capitation agreement with Elevance Health expanded in Q4 to include additional Medicare ...

Heidi Crane noted a $0.3 million increase in net interest expense, which slightly offset operational gains. Net Revenue -- ...